Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 4.422
Filter
1.
FP Essent ; 541: 14-19, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38896826

ABSTRACT

Bacterial skin infections represent a significant health care burden. Cellulitis and erysipelas are rapidly spreading, painful, superficial skin infections, usually caused by streptococci or Staphylococcus aureus. Folliculitis is an infection of hair follicles mostly caused by S aureus. Simple folliculitis typically is self-limited. Topical benzoyl peroxide is a first-line nonantibiotic treatment. Mupirocin and clindamycin are topical antibiotic options. For treatment-resistant cases, oral cephalexin or dicloxacillin is an appropriate option. Impetigo is a common, self-limited infection in children. Bullous impetigo is caused by S aureus, and nonbullous impetigo is caused by beta-hemolytic streptococci, S aureus, or both. In most cases, topical mupirocin or retapamulin (Altabax) is effective. Oral antibiotics should be considered for household outbreaks or patients with multiple lesions. Abscesses are red, painful collections of purulence in the dermis and deeper tissues caused by S aureus or polymicrobial infections. Furuncles are abscesses of a hair follicle, whereas carbuncles involve several hair follicles. In recurrent cases of these lesions, culture of the exudate is recommended. Abscess, furuncle, and carbuncle management consists of incision and drainage. Oral antibiotics are not necessary in most cases but should be prescribed for patients with severe immunocompromise or systemic signs of infection. In bacterial skin infections, methicillin-resistant S aureus coverage should be considered for patients with infections that have not improved with treatment.


Subject(s)
Anti-Bacterial Agents , Cellulitis , Impetigo , Skin Diseases, Bacterial , Humans , Child , Anti-Bacterial Agents/therapeutic use , Adolescent , Impetigo/diagnosis , Impetigo/drug therapy , Skin Diseases, Bacterial/diagnosis , Skin Diseases, Bacterial/drug therapy , Skin Diseases, Bacterial/microbiology , Skin Diseases, Bacterial/therapy , Cellulitis/diagnosis , Cellulitis/drug therapy , Cellulitis/microbiology , Cellulitis/therapy , Folliculitis/diagnosis , Folliculitis/drug therapy , Folliculitis/microbiology , Erysipelas/diagnosis , Erysipelas/drug therapy , Abscess/diagnosis , Abscess/therapy , Abscess/microbiology , Furunculosis/diagnosis , Furunculosis/drug therapy , Furunculosis/therapy , Furunculosis/microbiology , Carbuncle/diagnosis , Carbuncle/therapy
2.
Clin Lab ; 70(6)2024 Jun 01.
Article in English | MEDLINE | ID: mdl-38868873

ABSTRACT

BACKGROUND: From June 2021 to July 2021, our hospital confirmed 3 cases of Mycobacterium infection in skin abscesses. All 3 patients underwent thread embedding and weight loss surgery at the same informal beauty institution, with a history of silk protein injection. None of the patients had any other underlying diseases or surgical history. Symptoms and signs show that the disease is acute and the course of the disease is short. All patients have found subcutaneous masses in different parts of the body. In most cases, the masses show redness and swelling, and some of the masses are accompanied by tenderness, wave sensation, and rupture. After some of the masses rupture, purulent secretions can be seen. METHODS: The pus secreted by the skin lesions of the three patients were cultured to a single bacterium, which was identified by MALDI-TOF MS. Multiple locus sequence typing (MLST) was performed using three specific genes (hsp65, rpoB, and secA1) and seven housekeeping genes (argH, cya, glpK, gnd, murC, pta, and purH). The results were queried through the MLST database of Mycobacterium abscess. RESULTS: All three strains of bacteria were Mycobacterium abscess type ST279 massiliense subtype. Three antibacterial drugs including cefmetazole, amikacin, and clarithromycin were administered in combination with 5-aminolevulinic acid photodynamic therapy (ALA-PDT). After 3 - 6 months, there was no obvious redness or swelling in the surrounding tissues of the wound, and no obvious purulent secretions were observed. All patients were cured and discharged from the hospital. After a follow-up of six months, there was no recurrence of the lesions. CONCLUSIONS: Medical institutions must strictly follow infection control guidelines and take preventive measures to prevent such incidents from happening again. ALA-PDT as a combination therapy for nontuberculous Mycobacterium (NTM) skin infections can improve treatment efficacy and shorten antibiotic usage time.


Subject(s)
Anti-Bacterial Agents , Disease Outbreaks , Mycobacterium Infections, Nontuberculous , Humans , Female , Mycobacterium Infections, Nontuberculous/epidemiology , Mycobacterium Infections, Nontuberculous/diagnosis , Mycobacterium Infections, Nontuberculous/microbiology , Adult , Anti-Bacterial Agents/therapeutic use , Skin Diseases, Bacterial/epidemiology , Skin Diseases, Bacterial/microbiology , Skin Diseases, Bacterial/diagnosis , Skin Diseases, Bacterial/drug therapy , Male , Middle Aged , Abscess/microbiology , Abscess/epidemiology , Abscess/diagnosis , Mycobacterium abscessus/isolation & purification , Mycobacterium abscessus/genetics , Nontuberculous Mycobacteria/isolation & purification , Nontuberculous Mycobacteria/genetics , Nontuberculous Mycobacteria/drug effects
3.
Diagn Microbiol Infect Dis ; 109(3): 116307, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38733753

ABSTRACT

The nocardiae are a complex group of bacteria belonging to the aerobic saprophytes actinomycetes. Although nocardiosis typically occurs in immunocompromised patients, infection may occasionally develop in immunocompetent patients as well. Here we describe a rare case of primary cutaneous nocardiosis due to Nocardia vinacea in an immunocompetent 79-year-old patient. Since cutaneous nocardiosis presents variably and mimics other cutaneous infections, acid-fast and Gram stainings on clinical samples are significant to obtain a rapid and presumptive diagnosis.


Subject(s)
Nocardia Infections , Nocardia , Skin Diseases, Bacterial , Humans , Nocardia Infections/diagnosis , Nocardia Infections/microbiology , Nocardia Infections/drug therapy , Nocardia/isolation & purification , Nocardia/genetics , Nocardia/classification , Aged , Skin Diseases, Bacterial/microbiology , Skin Diseases, Bacterial/diagnosis , Skin Diseases, Bacterial/drug therapy , Male , Anti-Bacterial Agents/therapeutic use , Skin/microbiology , Skin/pathology , Immunocompetence
4.
Am J Clin Dermatol ; 25(4): 623-637, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38578398

ABSTRACT

Secondary bacterial infections of common dermatoses such as atopic dermatitis, ectoparasitosis, and varicella zoster virus infections are frequent, with Staphylococcus aureus and Streptococcus pyogenes being the bacteria most involved. There are also Gram-negative infections secondary to common dermatoses such as foot dyshidrotic eczema and tinea pedis. Factors favoring secondary bacterial infections in atopic dermatitis, ectoparasitosis, and varicella zoster virus infections mainly include an epidermal barrier alteration as well as itch. Mite-bacteria interaction is also involved in scabies and some environmental factors can promote Gram-negative bacterial infections of the feet. Furthermore, the bacterial ecology of these superinfections may depend on the geographical origin of the patients, especially in ectoparasitosis. Bacterial superinfections can also have different clinical aspects depending on the underlying dermatoses. Subsequently, the choice of class, course, and duration of antibiotic treatment depends on the severity of the infection and the suspected bacteria, primarily targeting S. aureus. Prevention of these secondary bacterial infections depends first and foremost on the management of the underlying skin disorder. At the same time, educating the patient on maintaining good skin hygiene and reporting changes in the primary lesions is crucial. In the case of recurrent secondary infections, decolonization of S. aureus is deemed necessary, particularly in atopic dermatitis.


Subject(s)
Anti-Bacterial Agents , Dermatitis, Atopic , Humans , Dermatitis, Atopic/complications , Dermatitis, Atopic/microbiology , Dermatitis, Atopic/diagnosis , Anti-Bacterial Agents/therapeutic use , Superinfection/microbiology , Superinfection/diagnosis , Skin Diseases, Bacterial/microbiology , Skin Diseases, Bacterial/diagnosis , Skin Diseases, Bacterial/epidemiology , Staphylococcus aureus/isolation & purification , Coinfection/microbiology
5.
Front Cell Infect Microbiol ; 14: 1329235, 2024.
Article in English | MEDLINE | ID: mdl-38638828

ABSTRACT

The metagenomic next-generation sequencing (mNGS) method is preferred for genotyping useful for the identification of organisms, illumination of metabolic pathways, and determination of microbiota. It can accurately obtain all the nucleic acid information in the test sample. Anthrax is one of the most important zoonotic diseases, infecting mainly herbivores and occasionally humans. The disease has four typical clinical forms, cutaneous, gastrointestinal, inhalation, and injection, all of which may result in sepsis or meningitis, with cutaneous being the most common form. Here, we report a case of cutaneous anthrax diagnosed by mNGS in a butcher. Histopathology of a skin biopsy revealed PAS-positive bacilli. Formalin-fixed paraffin-embedded (FFPE) tissue sample was confirmed the diagnosis of anthrax by mNGS. He was cured with intravenous penicillin. To our knowledge, this is the first case of cutaneous anthrax diagnosed by mNGS using FFPE tissue. mNGS is useful for identifying pathogens that are difficult to diagnose with conventional methods, and FFPE samples are simple to manage. Compared with traditional bacterial culture, which is difficult to cultivate and takes a long time, mNGS can quickly and accurately help us diagnose anthrax, so that anthrax can be controlled in a timely manner and prevent the outbreak of epidemic events.


Subject(s)
Anthrax , Skin Diseases, Bacterial , Male , Humans , Anthrax/diagnosis , Paraffin Embedding , Formaldehyde/therapeutic use , High-Throughput Nucleotide Sequencing/methods , Metagenomics/methods , Sensitivity and Specificity
6.
Adv Sci (Weinh) ; 11(23): e2309622, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38582511

ABSTRACT

Bacterial skin infections are highly prevalent and pose a significant public health threat. Current strategies are primarily focused on the inhibition of bacterial activation while disregarding the excessive inflammation induced by dead bacteria remaining in the body and the effect of the acidic microenvironment during therapy. In this study, a novel dual-functional MgB2 microparticles integrated microneedle (MgB2 MN) patch is presented to kill bacteria and eliminate dead bacteria for skin infection management. The MgB2 microparticles not only can produce a local alkaline microenvironment to promote the proliferation and migration of fibroblasts and keratinocytes, but also achieve >5 log bacterial inactivation. Besides, the MgB2 microparticles effectively mitigate dead bacteria-induced inflammation through interaction with lipopolysaccharide (LPS). With the incorporation of these MgB2 microparticles, the resultant MgB2 MN patches effectively kill bacteria and capture dead bacteria, thereby mitigating these bacteria-induced inflammation. Therefore, the MgB2 MN patches show good therapeutic efficacy in managing animal bacterial skin infections, including abscesses and wounds. These results indicate that reactive metal borides-integrated microneedle patches hold great promise for the treatment of clinical skin infections.


Subject(s)
Anti-Bacterial Agents , Needles , Animals , Anti-Bacterial Agents/administration & dosage , Mice , Skin Diseases, Bacterial/microbiology , Skin Diseases, Bacterial/drug therapy , Disease Models, Animal , Humans , Transdermal Patch , Microinjections/methods
8.
Diagn Microbiol Infect Dis ; 109(2): 116235, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38458096

ABSTRACT

OBJECTIVES: Ceftazidime-avibactam (CAZ-AVI) is an option for infections caused by MDR gram-negative bacilli. In this study, we aimed to analyze the in vitro antimicrobial activity of CAZ-AVI and other antimicrobial agents against gram-negative bacilli that were collected in Colombia between 2019 and 2021 from patients with bacteremia and skin and soft-tissue infections (SSTIs). METHODS: A total of 600 Enterobacterales and 259 P. aeruginosa strains were analyzed. The phenotypic resistance of isolates, particularly non-susceptibility to meropenem, multidrug-resistant (MDR) isolates, and difficult-to-treat (DTR) P. aeruginosa, was evaluated according to CLSI breakpoints. RESULTS: Enterobacterales had the most susceptibility to CAZ-AVI (96.5 %) and tigecycline (95 %). Tigecycline and CAZ-AVI were the antimicrobial agents with the most in vitro activity against carbapenem-resistant Enterobacterales (CRE). CAZ-AVI was the antimicrobial treatment with the most activity against P. aeruginosa. CONCLUSIONS: Tigecycline and CAZ-AVI were the antimicrobial agents with the most activity against CRE and MDR Enterobacterales. For P. aeruginosa, CAZ-AVI was the antimicrobial treatment with the most in vitro activity.


Subject(s)
Anti-Bacterial Agents , Azabicyclo Compounds , Bacteremia , Ceftazidime , Drug Combinations , Gram-Negative Bacteria , Microbial Sensitivity Tests , Soft Tissue Infections , Tigecycline , Humans , Ceftazidime/pharmacology , Soft Tissue Infections/microbiology , Soft Tissue Infections/drug therapy , Colombia , Azabicyclo Compounds/pharmacology , Anti-Bacterial Agents/pharmacology , Bacteremia/microbiology , Bacteremia/drug therapy , Gram-Negative Bacteria/drug effects , Tigecycline/pharmacology , Pseudomonas aeruginosa/drug effects , Drug Resistance, Multiple, Bacterial , Gram-Negative Bacterial Infections/microbiology , Gram-Negative Bacterial Infections/drug therapy , Enterobacteriaceae/drug effects , Skin Diseases, Bacterial/microbiology , Skin Diseases, Bacterial/drug therapy
9.
J Dermatolog Treat ; 35(1): 2329248, 2024 Dec.
Article in English | MEDLINE | ID: mdl-38479408

ABSTRACT

Background: Pyoderma vegetans (PV) is a rare neutrophilic dermatosis of unknown etiology. Currently, there are no treatment guidelines for PV. Systemic steroids are often used as first-line therapy, but recurrence upon discontinuation or tapering is common.Materials and methods: We tested the efficacy of doxycycline at a dose of 200 mg/d to treat resistant PV.Results: After 4 weeks of treatment we noticed a significant improvement in the clinical appearance of PV.Conclusions: Our case demonstrates the potential utility of doxycycline as a systemic steroid-sparing agent in the treatment of PV.


Subject(s)
Pemphigus , Pyoderma Gangrenosum , Pyoderma , Skin Diseases, Bacterial , Humans , Doxycycline/therapeutic use , Pyoderma/drug therapy , Pyoderma/etiology , Organic Chemicals
10.
J Cutan Pathol ; 51(6): 403-406, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38419370

ABSTRACT

Cutaneous pseudolymphomas are a wide group of diseases mimicking cutaneous lymphoma. They comprise several skin conditions with different etiopathogenesis, clinical-pathological features, and prognosis, which may occur in the absence of an identifiable trigger factor or after administration of medications or vaccinations, tattoos, infections, or arthropod bites. They present with different manifestations: from solitary to regionally clustered lesions, up to generalized distribution and, in rare cases, erythroderma. They persist variably, from weeks to years, and resolve spontaneously or after antibiotics, but may recur in some cases. CD30+ T-cell pseudolymphomas are characterized by the presence of large, activated lymphoid cells, generally in response to viral infections, arthropod assault reactions, and drug eruptions. Stenotrophomonas maltophilia is a ubiquitous Gram-negative bacillus responsible for opportunistic infections in immunocompromised patients. Infection of intact skin in immunocompetent patients is particularly rare. Here, we report a case of a man presenting an isolated nodule histopathologically mimicking a primary cutaneous CD30+ T-cell lymphoproliferative disorder.


Subject(s)
Gram-Negative Bacterial Infections , Lymphoproliferative Disorders , Pseudolymphoma , Skin Diseases, Bacterial , Humans , Male , Middle Aged , Diagnosis, Differential , Gram-Negative Bacterial Infections/diagnosis , Gram-Negative Bacterial Infections/microbiology , Gram-Negative Bacterial Infections/pathology , Immunocompetence , Ki-1 Antigen/metabolism , Lymphoproliferative Disorders/pathology , Lymphoproliferative Disorders/microbiology , Lymphoproliferative Disorders/diagnosis , Pseudolymphoma/pathology , Pseudolymphoma/diagnosis , Pseudolymphoma/microbiology , Pseudolymphoma/immunology , Skin Diseases, Bacterial/pathology , Skin Diseases, Bacterial/diagnosis , Skin Diseases, Bacterial/microbiology , Skin Diseases, Bacterial/immunology , Stenotrophomonas maltophilia/isolation & purification , T-Lymphocytes/immunology , T-Lymphocytes/pathology
11.
Dermatologie (Heidelb) ; 75(6): 492-495, 2024 Jun.
Article in German | MEDLINE | ID: mdl-38361042

ABSTRACT

We report a 77-year-old man with a skin abscess caused by Actinomyces radingae. Targeted antibiotic therapy with amoxicillin/clavulanic acid for 6 weeks resulted in clearing of the infection. A. radingae is a rare pathogenic agent of skin and soft tissue infections. As with other Actinomyces infections, the early identification of the pathogen and specific antibiotic therapy is crucial for successful resolution of the infection because of the chronic course and the long treatment time needed. Usually, A. radingae is sensitive to ß­lactam antibiotics.


Subject(s)
Abscess , Actinomyces , Actinomycosis , Anti-Bacterial Agents , Skin Diseases, Bacterial , Humans , Male , Aged , Abscess/microbiology , Abscess/drug therapy , Abscess/diagnosis , Actinomycosis/drug therapy , Actinomycosis/diagnosis , Actinomycosis/microbiology , Actinomycosis/pathology , Actinomyces/isolation & purification , Anti-Bacterial Agents/therapeutic use , Skin Diseases, Bacterial/microbiology , Skin Diseases, Bacterial/drug therapy , Skin Diseases, Bacterial/diagnosis , Amoxicillin-Potassium Clavulanate Combination/therapeutic use , Treatment Outcome
12.
Vet Res Commun ; 48(3): 1459-1470, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38321337

ABSTRACT

An urgent need to find alternative antimicrobial compounds effective in the prevention and treatment of skin infections led us to study the inhibitory activity of eight plant-derived bioactive compounds (betulin, curcumin, glycyrrhizic acid, guaiazulene, piperine, quercetin, quinine, tannic acid) against 14 canine skin isolates (11 Gram-positive and three Gram-negative bacteria) selected based on antibiotic resistance and virulence features. The minimum inhibitory concentration (MIC) and the minimum bactericidal concentration (MBC) were determined using the broth microdilution method. In detail, the results for the eight different plant compounds showed their inhibitory activity in the concentration range from 0.04 to more than 16 mg/ml (MIC) and from 0.25 to more than 16 mg/ml (MBC). The most potent compounds appear to be tannic acid, followed by quinine and curcumin (MIC 0.04-16.0 mg/ml). The most susceptible strain to the tested agents in general was Bacillus cereus AE13, while Enterococcus faecium AA14 was the most resistant strain (the highest MICs) among the tested bacteria. The two most potent plant-derived compounds (tannic acid and quinine) were tested in mixture in different ratios (1:1, 1:2, 2:1). The lowest MIC and MBC values were observed for the 1:2 ratio, which was used for preparation of creams with different cream bases. One of the cream formulations (cream F) was effective up to 63.0 mg/ml (MIC) with a microbial inactivation time of 1-6 h according to the tested strain. This study provides evidence that some plant-derived compounds could have an antimicrobial effect against canine skin bacteria, the strength of which is bacterial strain dependent.


Subject(s)
Anti-Bacterial Agents , Microbial Sensitivity Tests , Animals , Dogs , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/chemistry , Plant Extracts/pharmacology , Plant Extracts/chemistry , Dog Diseases/drug therapy , Dog Diseases/microbiology , Skin Cream/pharmacology , Skin Diseases, Bacterial/veterinary , Skin Diseases, Bacterial/drug therapy , Skin Diseases, Bacterial/microbiology
13.
Medicine (Baltimore) ; 103(3): e36921, 2024 Jan 19.
Article in English | MEDLINE | ID: mdl-38241573

ABSTRACT

RATIONALE: Anthrax is a severe zoonotic infectious disease caused by Bacillus anthracis. Most reported cases were traditionally diagnosed through culture and microscopy. We reported here the second case of cutaneous anthrax diagnosed by metagenomic next-generation sequencing (mNGS). PATIENT CONCERNS: A 63-year-old man had a history of contact with an unwell sheep, developing local redness and swelling on wrist. The dorsal side of the left hand and forearm, with tension blisters on the back of the left. DIAGNOSIS: B anthracis was detected from culturing and mNGS of tension blisters. INTERVENTIONS: On the second day of admission, the patient was administered 3.2 million units of penicillin every 6 hours, and isolated and closely observed. OUTCOMES: The patient improves and is discharged. LESSONS: Traditional bacterial cultures are time-consuming, while mNGS offers the advantage of accurate, quick, high-throughput, unbiased sequencing of all genetic material in a sample, which is a good technical tool for assisting in the diagnosis of rare pathogen infections.


Subject(s)
Anthrax , Bacillus anthracis , Skin Diseases, Bacterial , Male , Humans , Animals , Sheep , Middle Aged , Anthrax/diagnosis , Anthrax/microbiology , Blister , Skin Diseases, Bacterial/diagnosis , Bacillus anthracis/genetics , High-Throughput Nucleotide Sequencing
14.
Pediatr Dermatol ; 41(3): 497-500, 2024.
Article in English | MEDLINE | ID: mdl-38173086

ABSTRACT

Mycobacterium avium-intracellulare (MAC) infection may have different skin manifestations, including cutaneous granulomas. Granulomatous skin reactions have distinct morphologic and histopathologic appearances. We present the case of an adolescent male with cutaneous MAC, misdiagnosed as sarcoidosis after initial biopsy results, demonstrated preservation of reticulin fibers and absence of organisms within granulomas. Sarcoidal granulomas often stain positive for reticulin fibers, which could be used to distinguish them from the infectious kind. This case should alert clinicians to the fact that the presence or quantity of intact reticular fibers may not be a reliable tool to differentiate between a sarcoidal and an infectious granuloma. Our case also highlights the diagnostic challenge of cutaneous MAC infection.


Subject(s)
Mycobacterium avium-intracellulare Infection , Sarcoidosis , Humans , Male , Mycobacterium avium-intracellulare Infection/diagnosis , Diagnosis, Differential , Sarcoidosis/diagnosis , Adolescent , Skin Diseases, Bacterial/diagnosis , Skin Diseases, Bacterial/microbiology , Mycobacterium avium Complex/isolation & purification , Biopsy
15.
Curr Opin Infect Dis ; 37(2): 71-79, 2024 04 01.
Article in English | MEDLINE | ID: mdl-38179868

ABSTRACT

PURPOSE OF REVIEW: There are aspects of skin and soft tissue infections (SSTIs) that remain unresolved, such as current numbers, classification criteria, how best to define severity and predict the outcome, what diagnostic tests to perform, what new treatment options are available, or what the duration of antibiotic treatment should be. We have reviewed the literature over the last 18 months to clarify these issues and provide our opinion. RECENT FINDINGS: SSTIs are common and among the top 10 most frequent infections worldwide. They represent a burden on the healthcare system and have a major impact on the quality of life of patients. Regarding classification, the Infectious Diseases Society of America (IDSA) provides a practical guide that distinguishes between uncomplicated and complicated infections, acute and chronic wound infections, and necrotising and nonnecrotizing infections based on skin extension and tissue necrosis. With new microbiological and imaging diagnostic techniques, SSTIs can now be better diagnosed. New PCR techniques are available, and mass spectrometry can be applied to samples collected in liquid transport media. Moreover, new treatment methods such as photodynamic therapy, reactive oxygen, and phages are emerging. SSTI patients can be treated with shorter antibiotic courses if they receive an active drug with good tissue penetration. Antibiotic treatment in necrotizing infections can be shortened to 48 h after the last debridement. SUMMARY: SSTIs remain a challenge regarding rapid and accurate diagnosis and clinical management.


Subject(s)
Skin Diseases, Bacterial , Soft Tissue Infections , Humans , Quality of Life , Skin Diseases, Bacterial/diagnosis , Skin Diseases, Bacterial/drug therapy , Soft Tissue Infections/diagnosis , Soft Tissue Infections/drug therapy , Anti-Bacterial Agents/therapeutic use , Skin
16.
Curr Opin Infect Dis ; 37(2): 80-86, 2024 04 01.
Article in English | MEDLINE | ID: mdl-38277175

ABSTRACT

PURPOSE OF REVIEW: To provide a brief overview of drugs in Phase II and III of development for the treatment of acute bacterial skin and skin structure infections (ABSSSI), offering insights into potential customized treatment options. RECENT FINDINGS: Several drugs are currently in advanced stages of evaluation for the treatment of ABSSSI, and numerous molecules are entering in the early development phases. Notably, many of these drugs exhibit unique mechanisms of action and interesting antimicrobial spectrum. SUMMARY: Tailoring antibiotic therapy based on patient characteristics, likely pathogens, type, site and severity of ABSSSI is crucial. Given the inherent limitations of available treatments, the development of novel agents is a pivotal avenue. Such advancements hold promise for enhancing treatment efficacy and simplifying drug selection for ABSSSI in everyday clinical practice.


Subject(s)
Skin Diseases, Bacterial , Soft Tissue Infections , Humans , Soft Tissue Infections/drug therapy , Skin Diseases, Bacterial/drug therapy , Skin Diseases, Bacterial/microbiology , Anti-Bacterial Agents , Treatment Outcome
17.
J Cosmet Dermatol ; 23(5): 1527-1532, 2024 May.
Article in English | MEDLINE | ID: mdl-38178368

ABSTRACT

BACKGROUND: The rapid development of cosmetic injections has led to an increased incidence of nontuberculous mycobacterial (NTM) infection. PATIENTS AND METHODS: Here, we presented a case of cutaneous Mycobacterium abscessus infection subsequent to botulinum toxin injection for treating masseter hypertrophy, and reviewed the literature on skin and soft tissue infections caused by NTM after cosmetic injections. RESULTS AND CONCLUSIONS: The patient underwent surgical excision and regular antibiotic therapy and has had nearly 2 months of follow-up without any signs of infection. The diagnosis and treatment of NTM infection have always been challenging, and further research is needed to standardize and guide the treatment.


Subject(s)
Masseter Muscle , Mycobacterium Infections, Nontuberculous , Mycobacterium abscessus , Adult , Female , Humans , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/adverse effects , Anti-Bacterial Agents/therapeutic use , Botulinum Toxins, Type A/adverse effects , Botulinum Toxins, Type A/administration & dosage , Cosmetic Techniques/adverse effects , Hypertrophy , Masseter Muscle/abnormalities , Mycobacterium abscessus/isolation & purification , Mycobacterium Infections, Nontuberculous/drug therapy , Mycobacterium Infections, Nontuberculous/diagnosis , Mycobacterium Infections, Nontuberculous/etiology , Mycobacterium Infections, Nontuberculous/microbiology , Skin Diseases, Bacterial/diagnosis , Skin Diseases, Bacterial/microbiology , Skin Diseases, Bacterial/drug therapy , Skin Diseases, Bacterial/etiology
18.
Am J Trop Med Hyg ; 110(3): 483-486, 2024 Mar 06.
Article in English | MEDLINE | ID: mdl-38266303

ABSTRACT

Leprosy is a global health issue, causing long-term functional morbidity and stigma. Rapid diagnosis and appropriate treatment are important; however, early diagnosis is often challenging, especially in nonendemic areas. Here, we report a case of borderline lepromatous leprosy accompanied by dapsone-induced (neutropenia, anemia, and methemoglobinemia) and clofazimine-induced (skin discoloration and ichthyosis) side effects and type 1 leprosy reactions during administration of the multidrug therapy. The patient completely recovered without developing any deformities or visual impairment. To ensure early diagnosis and a favorable outcome, clinicians should be aware of the diminished sensation of skin lesions as a key physical finding and manage the drug toxicities and leprosy reactions appropriately in patients on multidrug therapy.


Subject(s)
Hypersensitivity , Leprosy, Borderline , Leprosy, Lepromatous , Leprosy, Multibacillary , Leprosy , Peripheral Nervous System Diseases , Skin Diseases, Bacterial , Humans , Clofazimine/adverse effects , Dapsone/adverse effects , Drug Therapy, Combination , Leprostatic Agents/adverse effects , Leprosy/pathology , Leprosy, Borderline/diagnosis , Leprosy, Borderline/drug therapy , Peripheral Nervous System Diseases/drug therapy , Leprosy, Multibacillary/drug therapy , Leprosy, Lepromatous/diagnosis , Leprosy, Lepromatous/drug therapy , Leprosy, Lepromatous/pathology
19.
Int J Infect Dis ; 140: 104-109, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38195038

ABSTRACT

OBJECTIVES: Bacillus anthracis infection is a worldwide zoonosis that affects the most vulnerable population and has a high mortality rate without treatment, especially in non-cutaneous presentations. Cutaneous scarification is still common in some regions of the world for the treatment of certain diseases as part of traditional medicine. We describe a series of cutaneus anthrax from a rural setting in Angola where cutaneus scarification is common. CASE PRESENTATION: This is a retrospective observational study describing a series of cutaneous anthrax cases from Cubal (Angola), many of whom were treated with skin scarification before admission. A total of 26 cases were diagnosed from January 2010 to December 2018. None of the cases were confirmed and eight (30.8%) were probable cases according to the Centers for the Disease Control and Prevention anthrax case definition. The median age was 11 (4.7-30.5) years, 17 (65.4%) had lesions on the head, face, or neck and 15 (57.7%) were treated with cutaneous scarification. Nine (34.6%) patients died. Traditional cutaneous scarification was significantly associated with cutaneous superinfection, respiratory, systemic involvement, and death. CONCLUSION: Our case series points to increased complications and worse outcome of cutaneous anthrax disease if treated with skin scarification.


Subject(s)
Anthrax , Bacillus anthracis , Skin Diseases, Bacterial , Child , Humans , Angola , Anthrax/diagnosis , Anthrax/drug therapy , Anthrax/epidemiology , Anti-Bacterial Agents/therapeutic use , Skin Diseases, Bacterial/drug therapy , Skin Diseases, Bacterial/epidemiology , Skin Diseases, Bacterial/diagnosis , Retrospective Studies
20.
Australas J Dermatol ; 65(1): 67-70, 2024 Feb.
Article in English | MEDLINE | ID: mdl-37985465

ABSTRACT

Nocardia primarily affects immunocompromised individuals, and Infection with Nocardia is uncommon and primary cutaneous nocardiosis caused by percutaneous inoculation is even rarer. Primary cutaneous nocardiosis remains a diagnostic challenge and should be considered in the differential diagnosis for any superficial cutaneous infection that arises in patients with normal immune function. We report a case that was diagnosed with primary cutaneous Nocardia by metagenomic next-generation sequencing technology.


Subject(s)
Dermatitis , Nocardia Infections , Nocardia , Skin Diseases, Bacterial , Humans , Nocardia Infections/diagnosis , Nocardia Infections/drug therapy , Skin Diseases, Bacterial/diagnosis , Skin Diseases, Bacterial/drug therapy , Nocardia/genetics , High-Throughput Nucleotide Sequencing , Immunity
SELECTION OF CITATIONS
SEARCH DETAIL
...